We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Diagnostic Tests Evaluated for Human Leptospirosis

By LabMedica International staff writers
Posted on 08 Aug 2013
The diagnosis of leptospirosis is often performed by the microscopic agglutination test (MAT) or by culture, but is confined to specialized laboratories.

Rapid Diagnostic Tests (RDTs) can be used for easy point-of-care diagnosis and three commercial kits have been evaluated for their diagnostic performance and compared with other standard assays. More...


Scientists at the Royal Tropical Institute (KIT; Amsterdam, The Netherlands) tested samples sent to their laboratory for leptospirosis diagnosis from July 2001 to August 2012. Blood, plasma, serum, and urine samples were cultured. The MAT was performed with a panel of live leptospires, and consisted of 16 strains of pathogenic serovars. An in-house enzyme-linked immunosorbent assay (ELISA) was developed for the detection of Leptospira-specific immunoglobulin M antibodies (IgM ELISA) and was performed with antigen prepared from the local strain Wijnberg (serovar Copenhageni, serogroup Icterohaemorrhagiae).

Three rapid diagnostic serological tests were used: Lepto Tek Dri Dot and Lepto Tek Lateral Flow (Organon Teknika B.V.; Boxtel, the Netherlands); and Leptocheck-WB, (Zephyr Biomedicals; Verna, Goa, India). Lepto Tek Lateral Flow and Leptocheck-WB are lateral flow immunochromatographic tests and LeptoTek Dri Dot is a latex agglutination assay and detects Leptospira-specific antibodies (IgM and IgG) in human sera.

The overall sensitivity for the LeptoTek Dri Dot was 75%, for the Lepto Tek Lateral, it was 78% Flow and 78% for the Leptocheck-WB. Specificity ranged from 95% to 98% in the three RDTs. Based on the first submitted sample the sensitivity was low, 51% for LeptoTek Dri Dot, 69% for Lepto Tek Lateral Flow, and 55% for Leptocheck-WB, but substantially increased when the results of paired samples were combined, although accompanied by a lower specificity, 82% for Lepto Tek Dri Dot, 86% for Lepto Tek Lateral Flow, and 80% for Leptocheck-WB.


The authors concluded that The LeptoTeK Lateral Flow presents in all scenarios with the best sensitivity and equally good specificity of all three RDT tests. All three tests, LeptoTek Dri Dot, LeptoTek Lateral Flow, and Leptocheck-WB present useful antibody tests contributing to the diagnosis of leptospirosis. However, since the overall sensitivity of the tested RDTs did not exceed 80%, one should be cautious to rely only on an RDT result, and confirmation by reference tests is strongly recommended. The study was published on July 11, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Dutch Royal Tropical Institute

Organon Teknika B.V

Zephyr Biomedicals



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.